Brady Park retweetledi

In people with diabetes or obesity and cardiovascular risk, semaglutide boosts regenerative cells and reduces inflammation, supporting natural vessel repair. Read more about the SEMA-VR trial in #EHJ.
doi.org/10.1093/eurhea…
#cardiotwitter #ESCcongress @ESC_Journals @escardio

English



















